chronic disease

FDA
Health Tech

FDA introduces TEMPO model to complement CMS ACCESS model

FDA will select 40 devices that can benefit the treatment of chronic conditions but have not yet been authorized for market use by the agency.
Emma Beavins Dec 5, 2025 4:35pm
Top view glucose meter lancet pen insulin stethoscope and syringe on blue background

Virtual women's health clinic Visana clinches $24M to scale

Sep 30, 2025 2:28pm
Two dosing pens of semaglutide

Omada touts strong results of GLP-1 companion program

Sep 8, 2025 3:00pm
woman on phone

American Heart Association, Cadence partner on RPM pilot

Aug 26, 2025 4:45pm
Nutritionist concept

Elevance Health expands food as medicine support in primary care

Aug 18, 2025 3:15pm
Omada Health executive ring the opening bell at Nasdaq

Omada Health reports 49% year over year growth in Q1 post-IPO

Aug 8, 2025 10:00am